A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Popularity Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering substances of uncertain source.
Some experts stated the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Response and Material Removal
According to TikTok, the service has removed problematic material and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.
After minutes of entering one community, a seller posted contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Item Details and Costs
Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.
